HealthQuill Articles by: HealthQuill
Climate Health Medical

‘100,000 Afghani kids face a bleak future amidst strife and temblors’

HQ Team January 16, 2024: Over 96,000 children in Afghanistan are in dire need of support almost 100 days after earthquakes devastated the

Read More
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received Breakthrough Therapy Designation from the USFDA.
Drugs Medical Pharma

Merck’s Keytruda receives FDA nod for cervical cancer treatment

HQ Team January 13, 2024: The U.S. Food and Drug Administration (FDA) has granted approval for the expanded use of Merck & Co’s

Read More
Vertex Pharmaceuticals, a US-based biotechnology company, announced its mid-stage trial on a non-opioid oral drug for patients with diabetic peripheral neuropathy has yielded positive results.
Drugs Medical Pharma

Venture capitalists, scientists plan biomedical research unit for new drugs

HQ Team January 13, 2024: High-profile scientists and financiers are pooling resources to launch a biomedical research facility that they claim will offer

Read More
The first human trials for a vaccine against Nipah virus have been started by the University of Oxford, according to a statement.
Drugs Health Pharma

University of Oxford starts human trials to develop vaccine against Nipah virus 

HQ Team January 11, 2023: The first human trials for a vaccine against Nipah virus have been started by the University of Oxford,

Read More
British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company  Aiolos Bio Inc., which makes medicines to treat asthma.
Drugs Health Pharma

GSK Plc., to buy asthma drugmaker Aiolos Bio for $1.4 billion  

HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company  Aiolos Bio Inc., which makes

Read More
Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in lowering blood sugar levels.
Drugs Health Pharma

Novo Nordisk diabetes drug meets trial goals against insulin glargine

 HQ Team January 9, 2023: Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in

Read More
Merck & Co., will acquire Harpoon Therapeutics, Inc., for $680 million to expand its cancer drug portfolio — a transaction expected to close by the middle of this year.
Drugs Health Pharma

Merck to buy Harpoon for $680 million to step up cancer portfolio

HQ Team January 8, 2024: Merck & Co., will acquire Harpoon Therapeutics, Inc., for $680 million to expand its cancer drug portfolio —

Read More
Johnson & Johnson will buy Ambrx Biopharma, Inc., a company developing targeted chemotherapy treatments, for $2 billion in cash.
Drugs Health Pharma

J&J to purchase Ambrx Biopharma for $2 billion in all-cash deal

HQ Team January 8, 2023: Johnson & Johnson will buy Ambrx Biopharma, Inc., a company developing targeted chemotherapy treatments, for $2 billion in cash.

Read More
About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave of the Covid-19 pandemic, according to a study.
Drugs Health Pharma

Antimalarial drug may have killed 17,000 people in first Covid-19 wave

HQ Team January 8, 2024: About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave

Read More
The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared to two weeks prior, according to the National Public Health Agency.
Drugs Health Pharma

JN.1 sub-variant Covid-19 cases rise to 62% in the US, says CDC 

HQ Team January 8, 2023: The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared

Read More